Analyst Ratings for Phathom Pharmaceuticals (PHAT) [Sells]
PHAT Rating Summary
PHAT Price Target Summary
- Highest: $28.00 (H.C. Wainwright)
- Lowest: $10.00 (Goldman Sachs)
- Average: $19.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$19.00 (+108.1%)
* Over Last 12-Mos
Rating Score: 8.9 / 10
Percentile Rank: 89%
Avg. $ Target:
$19.00 (+108.1%)
* Over Last 12-Mos
Rating Score: 8.9 / 10
Percentile Rank: 89%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|
